Rabeprazole API
Benzoimidazole-class PPI API manufactured under WHO-GMP. Offers low related substances and is optimised for rapid conversion to enteric pellets or tablets.
Product overview
Rabeprazole is a proton pump inhibitor used for GERD, duodenal ulcers and H. pylori eradication.
An active pharmaceutical ingredient (API) is the biologically active component of a medicine; formulators combine it with excipients to produce the finished dosage form.
Pharmaceutical applications
- Manufacture of finished acid-suppression dosage forms.
- Pellet, granule and tablet development by formulation companies.
Product specifications
- Product
- Rabeprazole API
- Form
- Active pharmaceutical ingredient
- Therapeutic category
- Anti-Ulcerant
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Rabeprazole API to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all apis Manufacturing capabilities
Other Rabeprazole products from Rraynex
- Rabeprazole + Domperidone — Granules
- Rabeprazole DC — Granules
- 2-((((4-(3-methoxypropoxy)-3-methylpyridine-2-yl)methyl)thio)-1H-benzo[d]imidazole — Intermediate
- 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine HCl — Intermediate
- Rabeprazole + Domperidone — Pellets
- Rabeprazole + Itopride — Pellets
- Rabeprazole + Levosulpiride — Pellets
- Rabeprazole EC — Pellets
- Rabeprazole MUPS — Pellets
- Rabeprazole Sodium EC — Pellets
- Rabeprazole Sodium EC + Aceclofenac SR — Pellets